Exploring gastric cancer genetics: A turning point in common variable immunodeficiency

Area of Science:

• Genomic Medicine
• Cancer Genomics
• Immunology

Background:

• Gastric cancer (GC) is a leading cause of cancer mortality and a frequent diagnosis in individuals with common variable immunodeficiency (CVID).
• Understanding the genetic underpinnings of GC in the context of CVID is crucial for improving patient outcomes.
• Previous research has not fully elucidated the germline variant landscape or transcriptomic parallels between GC and CVID.

Purpose of the Study:

• To conduct a large-scale genetic analysis of germline variants associated with CVID in gastric adenocarcinoma.
• To investigate the impact of these variants on tumor mutational load and GC progression.
• To explore transcriptomic similarities between GC and CVID.

Main Methods:

• Analysis of germline variants in 1591 GC samples for CVID-associated variants.
• Assessment of the impact of CVID-related variants on tumor mutational load.
• Transcriptomic comparison between GC and healthy gastric tissue, matched with CVID signatures.

Main Results:

• CVID-associated germline variants were identified in 60% of GC samples.
• A significant association was found between CVID-related variants and higher tumor mutational load in GC (P < .0001).
• Transcriptomic analysis revealed shared pathways in innate immunity and tumorigenesis, including upregulated oncogenes and downregulated immunomodulatory genes.

Conclusions:

• The study deepens the understanding of molecular factors influencing GC, particularly in patients with CVID.
• CVID-related variants play a clinically relevant role in GC progression and may impact immunotherapy response.
• Findings suggest novel therapeutic strategies targeting the interplay between immunodeficiency and cancer.